YSELTY

This brand name is authorized in Austria, France, Croatia, Italy, Lithuania

Active ingredients

The drug YSELTY contains one active pharmaceutical ingredient (API):

1 Linzagolix choline UNII VHS6SC660Q - LINZAGOLIX CHOLINE

Linzagolix is a selective, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist that inhibits endogenous GnRH signalling by binding competitively to GnRH receptors in the pituitary gland, thereby modulating the hypothalamic-pituitary-gonadal axis. Read about Linzagolix

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
YSELTY Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01CC04		H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CC Anti-gonadotropin-releasing hormones
Discover more medicines within H01CC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 62713042, 66783216
Country: IT	Agenzia del Farmaco	Identifier(s): 050222013, 050222025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1094959, 1094960